2008
DOI: 10.1016/j.ahj.2007.11.018
|View full text |Cite
|
Sign up to set email alerts
|

Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: A high-resolution magnetic resonance imaging trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
162
0
13

Year Published

2008
2008
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 246 publications
(181 citation statements)
references
References 23 publications
6
162
0
13
Order By: Relevance
“…It has been established (4) that the presence of certain features, such as fibrous cap rupture, large lipid rich/necrotic core (LR/NC), and intraplaque hemorrhage (IPH) significantly increases the risk of cerebrovascular ischemic events (stroke and transient ischemic attacks). Beyond diagnostic and prognostic applications, carotid MRI has been widely used during recent years in clinical trials investigating the effect of lipid-lowering therapies (5,6). For such studies, MRI can deliver direct quantitative measures characterizing plaque size, geometry, and tissue composition, which are of critical interest as surrogate endpoints reflecting the effect of intervention on its primary target.…”
mentioning
confidence: 99%
“…It has been established (4) that the presence of certain features, such as fibrous cap rupture, large lipid rich/necrotic core (LR/NC), and intraplaque hemorrhage (IPH) significantly increases the risk of cerebrovascular ischemic events (stroke and transient ischemic attacks). Beyond diagnostic and prognostic applications, carotid MRI has been widely used during recent years in clinical trials investigating the effect of lipid-lowering therapies (5,6). For such studies, MRI can deliver direct quantitative measures characterizing plaque size, geometry, and tissue composition, which are of critical interest as surrogate endpoints reflecting the effect of intervention on its primary target.…”
mentioning
confidence: 99%
“…35 Previous studies have shown that the LRNC of carotid atherosclerosis regresses after treatment with lipid-lowering drugs. 36 For symptomatic patients, therefore, early detection of LRNC size by using accurate MR imaging techniques and receiving systemic lipid-lowering therapy may be helpful for prevention of recurrent stroke.…”
Section: Discussionmentioning
confidence: 99%
“…4 In the ORION trial, individuals who were on very high-intensity therapy, 40-80 mg of rosuvastatin daily, experienced no change in carotid plaque volume. Rather, in all these individuals with a lipid-rich necrotic core at baseline, there was a mean decrease of 41% in the proportion of the vessel wall composed of the lipid-rich necrotic core.…”
Section: Cimt or Ldl-c?mentioning
confidence: 99%